The Incretin and Mitochondrial Pair combines Tirzepatide with MOTS-C for multi-pathway metabolic experiments in cell based models. One acts on incretin receptors, the other is mitochondrially derived, so the pair covers two separate arms of energy metabolism.
A combination of metabolic signalling compounds for multi-pathway experiments in cell based models.
Research profiles: Tirzepatide and MOTS-C
What is tested in this pair
This pair contains two products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Tirzepatide | 99.74% | Janoshik Analytical | 24 Sep 2026 | View |
| MOTS-C | 99.28% | Janoshik Analytical | 24 Sep 2026 | View |







